Quantcast
More

    Melbourne: Footballer Jackson Williams cleared of sexual assault after dragging nurse down a laneway

    Footballer who dragged a nurse down a laneway before off-duty cop pulled him off her is CLEARED of sexual assault after judge decided 'he...

    Jeffrey Toobin walks his dog after Zoom masturbation ordeal

    EXCLUSIVE: Jeffrey Toobin is pictured walking his dog under cover of darkness a day after it was revealed he was was caught masturbating on...

    Arabella Del Busso flaunts underboob in X-rated selfie

    Notorious former WAG Arabella Del Busso flaunts her toned abs and a generous glimpse of underboob in a skimpy white crop topBy Alisha Buaya...

    Warning over toxic trendy pink salt as it’s revealed some brands have dangerous levels of LEAD

    Warning over toxic trendy pink salt as it's revealed some brands have dangerous levels of LEAD and heavy metals - while white salt is...

    In Reversal, White House Approves Stricter Guidelines for Vaccine Makers

    The Food and Drug Administration released new guidelines on Tuesday for coronavirus vaccine developers — a step that had been held up for two weeks by top White House officials. The guidelines make it highly unlikely that a vaccine could be authorized by Election Day.

    The move, which was cleared by the White House’s Office of Management and Budget, appeared to be an abrupt reversal a day after The New York Times reported that White House officials, including Mark Meadows, the chief of staff, were blocking the guidelines. Top F.D.A. officials were caught by surprise when they learned midafternoon that the new guidelines had been cleared.

    The new recommendations, which do not carry the force of law, call for gathering comprehensive safety data in the final stage of clinical trials before an emergency authorization can be granted.

    The guidance was formally published hours after the F.D.A. had quietly released the information at the end of a document prepared for an upcoming meeting of its vaccine advisory committee.

    Since the start of the coronavirus pandemic, the F.D.A. has said that it has been seeking ways to accelerate the development of vaccines without sacrificing safety. In June, the agency released an initial set of guidelines to give vaccine developers a better idea of how the F.D.A. would decide if a vaccine were acceptable, either for an emergency use authorization or for a full license.

    Four vaccines have reached the final stage of testing, known as a Phase 3 trial, in the United States. A fifth is expected to start this month. President Trump has repeatedly suggested that a vaccine would be ready by Election Day, if not before.

    But with opinion polls showing public confidence declining about what could be a rushed coronavirus vaccine, the F.D.A. submitted a new set of guidelines to the White House for approval on Sept. 21, attempting to assure companies developing vaccines that they were being held to a common standard and to boost public confidence in the process.

    Among the recommendations, the agency advised vaccine makers to follow volunteers for a median of two months after the final dose. The F.D.A. also expected vaccine makers to document five cases of severe infection in people who received the placebo instead of the vaccine.

    The F.D.A. submitted the guidelines to the Office of Management and Budget for approval more than two weeks ago, but they stalled in part because of Mr. Meadows’s involvement, according to a senior administration official and others familiar with the situation.

    The White House objected that the guidelines would add unnecessary burdens on vaccine makers. In a conversation with Dr. Stephen M. Hahn, the F.D.A. commissioner, days after the guidelines were submitted, Mr. Meadows said the recommendations amounted to changing the rules on drugmakers in the throes of clinical trials, according to one senior administration official. He also suggested that Dr. Hahn was overly influenced by the career scientists who had drafted the document, the official said.

    Trump administration officials have the authority to intervene with such nonbinding documents, partly because of a 2019 executive order that tightened restrictions over their issuance.

    The F.D.A., however, continued to share parts of this guidance with vaccine developers in letters to the companies.

    “We’ve made it clear that we want to see a median of about two months of follow-up for any of the vaccines that comes in,” Dr. Peter Marks, the F.D.A.’s top regulator for vaccines, said in an interview on YouTube on Friday.

    In a statement Tuesday, the drug industry’s largest trade group, the Pharmaceutical Research and Manufacturers of America, said it supported the new guidelines.

    “We have engaged with the agency to support bringing greater transparency to the review process for COVID-19 vaccines,” the statement said. “We welcome the agency’s efforts to instill confidence in the rigorous safety of these potential vaccines.”

    Sharon LaFraniere contributed reporting from Washington.

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Latest Posts

    Grant Denyer is forced to deny rumours he’s returning to Channel Seven

    Grant Denyer is forced to deny rumours he's jumping ship to Channel Seven after Network 10 axed his show Dancing with the Stars By Alisha...

    Covid-19: Dan Andrews announces plans for outdoor dining but refuses to relax Melbourne restrictions

    This is just cruel, Dan: TV-obsessed premier uses his daily press conference for a stunt spruiking plans for more outdoor dining in Victoria -...

    In debate countdown, Trump holds rally, Biden does prep

    ERIE, Pa. (AP) — President Donald Trump pushed into arguably the most important state on the electoral map on Tuesday, opting for a rally...